| Affiliation: | 1. National Institute for Minamata Disease, Kumamoto, Japan;2. Brain Research Institute, Niigata University, Niigata, Japan;3. Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat “Rovira I Virgili”, Reus, Spain;4. Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan;5. Universidade Federal do Oeste do Pará, ICED-PPGBIO-PPGRNA-LABBEX, Santarém, Brazil;6. Akita University School of Medicine, Akita, Japan;1. National School of Public Health, Carlos III Institute of Health, Madrid, Spain;2. SUMMA 112, Madrid, Spain |
